Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy
- PMID: 17431381
Expression of CD40 and CD40L on tumor cells: the role of their interaction and new approach to immunotherapy
Abstract
In the review the modern insights on the role of expression of CD40 and CD40L and the role of their interaction on tumor cells growth are analyzed. Information about the structure and biologic properties of these molecules and their interaction is presented. The question on the role of CD40/CD40L interaction is highlighted in two aspects--the possibility of tumor growth inhibition and its stimulation. According to the mentioned aspects, immunologic mechanisms providing tumor growth inhibition (the role of dendritic cells, macrophages, monocytes, cytotoxic T-lymphocytes, natural killer cells etc.), and also the possibility of apoptotic events are discussed. Possibility of tumor growth stimulation upon the influence of CD40/CD40L interaction that could occur in some cases is analyzed as well. The data of literature about new approaches to immunotherapy of cancer based on CD40/CD40L interactionare summarized.
Similar articles
-
Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.Clin Cancer Res. 2001 Mar;7(3):691-703. Clin Cancer Res. 2001. PMID: 11297266
-
Prospects for CD40-directed experimental therapy of human cancer.Cancer Gene Ther. 2003 Jan;10(1):1-13. doi: 10.1038/sj.cgt.7700527. Cancer Gene Ther. 2003. PMID: 12489023 Review.
-
Adenovirus-mediated CD40 ligand gene-engineered dendritic cells elicit enhanced CD8(+) cytotoxic T-cell activation and antitumor immunity.Cancer Gene Ther. 2002 Feb;9(2):202-8. doi: 10.1038/sj.cgt.7700429. Cancer Gene Ther. 2002. PMID: 11857039
-
Adeno-associated virus mediated gene transfer into lung cancer cells promoting CD40 ligand-based immunotherapy.Virology. 2007 Nov 25;368(2):309-16. doi: 10.1016/j.virol.2007.07.006. Epub 2007 Aug 6. Virology. 2007. PMID: 17675129
-
CD40/CD40L signaling and its implication in health and disease.Biofactors. 2009 Nov-Dec;35(6):474-83. doi: 10.1002/biof.62. Biofactors. 2009. PMID: 19904719 Review.
Cited by
-
Immunogenicity and Immunoprotection of PCV2 Virus-like Particles Incorporating Dominant T and B Cell Antigenic Epitopes Paired with CD154 Molecules in Piglets and Mice.Int J Mol Sci. 2022 Nov 16;23(22):14126. doi: 10.3390/ijms232214126. Int J Mol Sci. 2022. PMID: 36430608 Free PMC article.
-
TNF-α promotes IFN-γ-induced CD40 expression and antigen process in Myb-transformed hematological cells.ScientificWorldJournal. 2012;2012:621969. doi: 10.1100/2012/621969. Epub 2012 Apr 1. ScientificWorldJournal. 2012. PMID: 22547990 Free PMC article.
-
Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.Clin Exp Immunol. 2009 Mar;155(3):412-22. doi: 10.1111/j.1365-2249.2008.03793.x. Clin Exp Immunol. 2009. PMID: 19220831 Free PMC article.
-
Double Strike Approach for Tumor Attack: Engineering T Cells Using a CD40L:CD28 Chimeric Co-Stimulatory Switch Protein for Enhanced Tumor Targeting in Adoptive Cell Therapy.Front Immunol. 2021 Nov 29;12:750478. doi: 10.3389/fimmu.2021.750478. eCollection 2021. Front Immunol. 2021. PMID: 34912334 Free PMC article.
-
CD40 pathway activation reveals dual function for macrophages in human endometrial cancer cell survival and invasion.Cancer Immunol Immunother. 2013 Feb;62(2):273-83. doi: 10.1007/s00262-012-1333-2. Epub 2012 Aug 18. Cancer Immunol Immunother. 2013. PMID: 22903346 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Research Materials